Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies ; volume:43 ; number:1 ; day:31 ; month:5 ; year:2024 ; pages:1-32 ; date:12.2024
Journal of experimental & clinical cancer research ; 43, Heft 1 (31.5.2024), 1-32, 12.2024
- Urheber
-
Pitts, Stephanie C.
Schlom, Jeffrey
Donahue, Renee N.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-024-03074-z
- URN
-
urn:nbn:de:101:1-2408082102178.397257716361
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pitts, Stephanie C.
- Schlom, Jeffrey
- Donahue, Renee N.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Soluble immune checkpoints in cancer: production, function and biological significance
Soluble immune checkpoints are elevated in patients with primary biliary cholangitis
Targeting immune checkpoints in hematological malignancies
Locoregional therapies combined with immune checkpoint inhibitors for liver metastases
Varied functions of immune checkpoints during cancer metastasis
Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications
Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis
Untersuchung der Rolle des Immun-Checkpoints VISTA im Pankreaskarzinom
Expression patterns of immune checkpoints in acute myeloid leukemia
Soluble immune checkpoints in cancer: production, function and biological significance
Soluble immune checkpoints are elevated in patients with primary biliary cholangitis
Targeting immune checkpoints in hematological malignancies
Locoregional therapies combined with immune checkpoint inhibitors for liver metastases
Varied functions of immune checkpoints during cancer metastasis
Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications
Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis
Untersuchung der Rolle des Immun-Checkpoints VISTA im Pankreaskarzinom
Expression patterns of immune checkpoints in acute myeloid leukemia
Soluble immune checkpoints in cancer: production, function and biological significance
Soluble immune checkpoints are elevated in patients with primary biliary cholangitis
Targeting immune checkpoints in hematological malignancies
Locoregional therapies combined with immune checkpoint inhibitors for liver metastases
Varied functions of immune checkpoints during cancer metastasis
Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications
Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis
Untersuchung der Rolle des Immun-Checkpoints VISTA im Pankreaskarzinom